Send the following on WhatsApp
Continue to ChatThe first experience on Lutetium (lu)-177 prostate specigic andigen (PSMA) treatment in castration resistant prostate cancer patients - https://avesis.ankara.edu.tr/yayin/6100940f-56b4-428f-b7bc-afbb49a0e9eb/the-first-experience-on-lutetium-lu-177-prostate-specigic-andigen-psma-treatment-in-castration-resistant-prostate-cancer-patients